Quarterly report pursuant to Section 13 or 15(d)

Interim Segment Information (Tables)

v3.20.2
Interim Segment Information (Tables)
3 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Segment information
Segment information for the three months ended June 30, 2020, and 2019, is set forth below: 
 
 
Three months ended June 30, 2020
(in thousands)
 
IBW
 
ISM
 
CNS
 
Total
Revenue
 
$
2,949

 
$
2,047

 
$
2,354

 
$
7,350

Cost of revenue
 
1,749


892

 
1,867

 
4,508

Gross profit
 
1,200

 
1,155

 
487

 
2,842

Gross margin
 
40.7
%
 
56.4
%
 
20.7
%
 
38.7
%
Research and development
 
349

 
382

 
214

 
945

Segment profit
 
$
851

 
$
773

 
$
273

 
1,897

Operating expenses:
 
 
 
 
 
 
 
 
Sales and marketing
 
 
 
 
 
 
 
1,376

General and administrative
 
 
 
 
 
 
 
1,210

Intangible amortization
 
 
 
 
 
 
 
226

Operating profit (loss)
 
 
 
 
 
 
 
(915
)
Other income, net
 
 
 
 
 
 
 
30

Income tax benefit (expense)
 
 
 
 
 
 
 
60

Net income (loss)
 
 
 
 
 
 
 
$
(825
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three months ended June 30, 2019
(in thousands)
 
IBW
 
ISM
 
CNS
 
Total
Revenue
 
$
2,923

 
$
3,095

 
$
2,984

 
$
9,002

Cost of revenue
 
1,951

 
1,516

 
2,289

 
5,756

Gross profit
 
972

 
1,579

 
695

 
3,246

Gross margin
 
33.3
%

51.0
%
 
23.3
%
 
36.1
%
Research and development
 
399

 
701

 
456

 
1,556

Segment profit
 
$
573

 
$
878

 
$
239

 
1,690

Operating expenses:
 
 
 
 
 
 
 
 
Sales and marketing
 
 
 
 
 
 
 
2,332

General and administrative
 
 
 
 
 
 
 
1,364

Intangible amortization
 
 
 
 
 
 
 
308

Operating profit (loss)
 
 
 
 
 
 
 
(2,314
)
Other income, net
 
 
 
 
 
 
 
164

Income tax benefit (expense)
 
 
 
 
 
 
 
(7
)
Net income (loss)
 
 
 
 
 
 
 
$
(2,157
)